Ro-24-6449

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRo-24-6449
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsStrokeCerebral Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ag
Active IndicationsN/A
Inactive IndicationsStrokeCerebral Infarction

Other Information

ATC CodeN/A
Related LinksN/A